Expansion Brings Advanced Probiotic Supplement Featuring 45 Billion CFUs and Delayed-Release Technology to Canadian Consumers
EXTON, Pa., Nov. 19, 2026 /CNW/ -- Kibow Biotech, a leading innovator in probiotic supplement research and development, today announced the availability of Renadyl in Canada, expanding access to its advanced probiotic formulation for Canadian consumers.
Developed through decades of probiotic research, Renadyl is a proprietary probiotic dietary supplement featuring 45 billion colony-forming units (CFUs) and delayed-release technology. Its formulation is designed to deliver live probiotics to the intestines, where they interact with the existing gut microbiota to temporarily modify gut flora and support microbial balance.
"Bringing Renadyl to Canada represents another important milestone in our mission to make innovative probiotic products available to more people around the world," said Mike Kane, President of Kibow Biotech. "Since 1997, Kibow Biotech has been committed to advancing probiotic science and developing formulations grounded in research. We are excited to expand access to Renadyl and introduce more Canadian consumers to our unique approach to supporting gut flora."
Renadyl features a proprietary blend of three probiotic strains. Each daily serving delivers 45 billion CFUs of live probiotics, supported by delayed-release capsule technology designed to help the beneficial bacteria survive digestion and reach the intestines alive.
Once in the intestinal environment, the probiotic strains interact with existing gut flora, participate in natural microbial activity, and help support a balanced and active gut microbiome.
"I am excited to see Renadyl becoming available to our neighbors in Canada," said James Fabin, founder of Dadvice TV. "Having access to innovative products and reliable information helps people make more informed decisions about their health. It is encouraging to see Kibow Biotech continuing to expand its reach."
The Canadian introduction reflects Kibow Biotech's continued commitment to scientific research, probiotic innovation, and expanding access to its proprietary formulations internationally.
Renadyl is now available to Canadian consumers at Renadyl.ca, where they can purchase the product and learn more about its formulation and the science behind it.
About Kibow Biotech, LLC
Kibow Biotech is a biotechnology company founded in 1997, based in suburban Philadelphia and specializing in the development and commercialization of scientifically formulated and clinically-tested probiotic dietary supplements.
Kibow specializes in probiotic supplements for supporting normal intestinal microflora. Established to help fight these rapidly growing health risks, Kibow provides the highest quality non-drug dietary supplements at affordable prices.
Contact Information:
Michelle Adams
President
PRISM Marketing
614-989-6373
[email protected]
SOURCE Kibow Biotech

Share this article